Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Cantor Fitzgerald
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “neutral” rating reissued by analysts at Cantor Fitzgerald in a report released on Monday, Benzinga reports. They currently have a $150.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective indicates a potential downside of 39.42% from the stock’s current price. A number […]
More Stories
Legal & General Group Plc Has $1.56 Million Stock Holdings in Ladder Capital Corp (NYSE:LADR)
Legal & General Group Plc lessened its stake in shares of Ladder Capital Corp (NYSE:LADR – Free Report) by 3.1%...
Invesco Ltd. Acquires 223,447 Shares of American Public Education, Inc. (NASDAQ:APEI)
Invesco Ltd. raised its holdings in American Public Education, Inc. (NASDAQ:APEI – Free Report) by 379.5% during the 4th quarter,...
Invesco Ltd. Sells 1,110,022 Shares of Lucid Group, Inc. (NASDAQ:LCID)
Invesco Ltd. trimmed its holdings in shares of Lucid Group, Inc. (NASDAQ:LCID – Free Report) by 36.3% during the 4th...
Legal & General Group Plc Reduces Stock Position in Under Armour, Inc. (NYSE:UA)
Legal & General Group Plc decreased its holdings in Under Armour, Inc. (NYSE:UA – Free Report) by 16.2% during the...
Renaissance Technologies LLC Sells 305,900 Shares of Zurn Elkay Water Solutions Co. (NYSE:ZWS)
Renaissance Technologies LLC cut its holdings in Zurn Elkay Water Solutions Co. (NYSE:ZWS – Free Report) by 84.0% during the...
Russell Investments Group Ltd. Sells 27,722 Shares of BRP Inc. (NASDAQ:DOOO)
Russell Investments Group Ltd. lowered its position in BRP Inc. (NASDAQ:DOOO – Free Report) by 92.7% during the 4th quarter,...